Thermo Fisher Scientific opens viral vector manufacturing facility in Plainville, Massachusetts.
Search Patheon
Search
US | EN
What’s the best path for your low soluble molecule?
Two molecules, both designed to treat the same condition, both with solubility challenges. Two biopharma companies racing to be first. Biopharma A chooses to move into trials as quickly as possible, while Biopharma B decides to address broader solubility concerns first. Who gets to market first may surprise you.